Biocon Ltd
NSE:BIOCON
Biocon Ltd
Cash from Financing Activities
Biocon Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biocon Ltd
NSE:BIOCON
|
Cash from Financing Activities
₹121.1B
|
CAGR 3-Years
120%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
87%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Cash from Financing Activities
-₹147.1m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Cash from Financing Activities
₹0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Cash from Financing Activities
₹0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Cash from Financing Activities
₹417.6m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Cash from Financing Activities
-₹183.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Cash from Financing Activities?
Cash from Financing Activities
121.1B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Cash from Financing Activities amounts to 121.1B INR.
What is Biocon Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
87%
Over the last year, the Cash from Financing Activities growth was 641%. The average annual Cash from Financing Activities growth rates for Biocon Ltd have been 120% over the past three years , and 87% over the past ten years .